Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Endocr Relat Cancer. 2008 Jul 30;15(4):1055–1060. doi: 10.1677/ERC-08-0104

Table 1.

Participant characteristics

Number (%) of participants
Characteristics Cases (n=367) Controls (n=602) ORs (95% CIs)a
Age (years) Matching factor
<45 78 (21) 124 (21)
45–54 107 (29) 176 (29)
55–64 90 (25) 157 (26)
>64 92 (25) 105 (24)
Ethnicity Matching factor
Caucasian 90 (25) 158 (26)
Japanese 102 (28) 175 (29)
Hawaiian 82 (24) 119 (20)
Filipino 43 (12) 80 (13)
Other 40 (11) 70 (12)
Family history of ovarian cancer
No 350 (95) 593 (99) 1.00 (reference)
Yes 17 (5) 9 (1) 3.74 (1.55–9.03)
Gravidity
Nulligravid 90 (25) 62 (10) 1.00 (reference)
1 46 (13) 70 (12) 0.55 (0.33–0.93)
2–3 138 (38) 256 (42) 0.49 (0.33–0.75)
≥4 93 (25) 214 (36) 0.38 (0.24–0.60)
Used oral contraceptives
No 197 (54) 190 (32) 1.00 (reference)
Yes 170 (46) 412 (68) 0.35 (0.25–0.49)
Had tubal ligation
No 304 (83) 413 (69) 1.00 (reference)
Yes 63 (17) 189 (31) 0.60 (0.42–0.86)
Menopausal status
Postmenopausal 239 (65) 378 (63) 1.00 (reference)
Premenopausal 128 (35) 224 (37) 0.51 (0.25–1.05)
Type of menopause
Natural menopause 203 (55) 329 (55) 1.00 (reference)
Hysterectomy 164 (45) 273 (45) 1.13 (0.66–1.97)
Use of menopausal hormones
Never used 265 (72) 392 (65) 1.00 (reference)
Estrogen only 34 (9) 50 (8) 0.85 (0.48–1.52)
Progesterone only 13 (4) 19 (3) 0.80 (0.36–1.77)
Combined estrogen and
progesterone
55 (15) 141 (24) 0.55 (0.36–0.84)
BMI
Underweight (BMI≤18.5) 6 (2) 18 (4) 1.00 (reference)
Normal (18.5<BMI<25) 141 (52) 218 (48) 1.23 (0.49–3.04)
Overweight (25≤BMI<30) 63 (23) 126 (28) 1.18 (0.62–4.08)
Obese (BMI≥30) 64 (23) 90 (20) 1.59 (0.57–4.71)
a

Odds ratios (ORs) and 95% confidence intervals (CIs) based on unconditional logistic regression models including all listed variables.